Biocompatibility Assessment of Liquid Artificial Vitreous Replacements: Relevance of In Vitro Studies

Survey of Ophthalmology

Volumn 52, Issue 3, 2007, Pages 289-299

  Matteucci, Andrea ^a   Formisano, Giuseppe ^b   Paradisi, Silvia ^b   Carnovale Scalzo, Giovanna ^c   Scorcia, Giovanni ^c   Caiazza, Salvatore ^b   Hoerauf, Hans ^d   Malchiodi Albedi, Fiorella ^b  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

biocompatibility; biomaterials; ocular endotamponades; partially fluorinated alkanes; perfluorocarbon liquids; retinal cell culture; vitreous

Indexed keywords

BIOMATERIAL;

ARTICLE; BIOCOMPATIBILITY; CELL CULTURE; CYTOTOXICITY; GENE EXPRESSION; HEALTH SURVEY; HUMAN; IN VITRO STUDY; INFLAMMATION; LIQUID; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL; RETINA CELL; VITREOUS BODY;

ANIMALS; BIOCOMPATIBLE MATERIALS; FLUOROCARBONS; HUMANS; MATERIALS TESTING; OPHTHALMIC SOLUTIONS; VITRECTOMY; VITREOUS BODY;

EID: 34247529125     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2007.02.004     Document Type: Article

References (77)

1. Anderson D.G., Levenberg S., and Langer R. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol 22 (2004) 863-866
2. Araiz J.J., Refojo M.F., Arroyo M.H., et al. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 34 (1993) 522-530
3. Blinder K.J., Peyman G.A., Paris C.L., et al. Vitreon, a new perfluorocarbon. Br J Ophthalmol 75 (1991) 240-244
4. Boveri M., Berezowski V., Price A., et al. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line. Glia 51 (2005) 187-198
5. Brazitikos P.D., Androudi S., D'Amico D.J., et al. Perfluorocarbon liquid utilization in primary vitrectomy repair of retinal detachment with multiple breaks. Retina 23 (2003) 615-621
6. Bruining M.J., Edelbroek-Hoogendoorn P.S., Blaauwgeers H.G., et al. New biodegradable networks of poly(N-vinylpyrrolidinone) designed for controlled nonburst degradation in the vitreous body. J Biomed Mater Res 47 (1999) 189-197
7. Bruining M.J., Blaauwgeers H.G., Kuijer R., et al. Biodegradable three-dimensional networks of poly(dimethylamino ethyl methacrylate). Synthesis, characterization and in vitro studies of structural degradation and cytotoxicity. Biomaterials 21 (2000) 595-604
8. Cai H., and Del Priore L.V. Gene expression profile of cultured adult compared to immortalized human RPE. Mol Vis 12 (2006) 1-14
9. Cavalieri F., Miano F., D'Antona P., et al. Study of gelling behavior of poly(vinyl alcohol)-methacrylate for potential utilizations in tissue replacement and drug delivery. Biomacromolecules 5 (2004) 2439-2446
10. Chang S., Ozmert E., and Zimmerman N.J. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol 106 (1988) 668-674
11. Chang S., Zimmerman N.J., Iwamoto T., et al. Experimental vitreous replacement with perfluorotributylamine. Am J Ophthalmol 103 (1987) 29-37
12. Comaratta M.R., and Chang S. Perfluorocarbon liquids in the management of complicated retinal detachments. Curr Opin Ophthalmol 2 (1991) 291-298
13. Conway M.D., Peyman G.A., Karaçorlu M., et al. Perfluorooctylbromide (PFOB) as a vitreous substitute in non-human primates. Int Ophthalmol 17 (1993) 259-264
14. Deli M.A., Abrahám C.S., Kataoka Y., et al. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 25 (2005) 59-127
15. Devin F., Jourdan T., Saracco J.B., et al. Experimental tolerance to perfluorodecalin used in prolonged intraocular tamponade. Ophthalmologica 209 (1995) 306-314
16. Elsing S.H., Fekrat S., Green W.R., et al. Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid. Ophthalmology 108 (2001) 45-48
17. Giaever I., and Keese C.R. Behavior of cells at fluid interfaces. Proc Natl Acad Sci U S A 80 (1983) 219-222
18. Giordano G.G., Refojo M.F., and Arroyo M.H. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR. Invest Ophthalmol Vis Sci 34 (1993) 2743-2751
19. Giordano G.G., and Refojo M.F. Silicone oils as vitreous substitutes. Prog Polym Sci 23 (1998) 509-532
20. Glaser B.M., Carter J.B., Kuppermann B.D., et al. Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy. Ophthalmology 98 (1991) 1613-1621
21. Hammer M.E., Rinder D.F., and Hicks E.L. Tolerance of perfluorocarbons, fluorosilicone, and silicone liquids in the vitreous. In: Freeman HM, and Tolentino FL (Eds). Proliferative vitreoretinopathy (PVR) (1988), Springer Verlag, New York 156-161
22. Hashizoe M., Ogura Y., Takanashi T., et al. Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits. Curr Eye Res 16 (1997) 633-639
23. Hegazy HM, Peyman GA, Liang C, et al: Use of perfluorocarbon liquids, silicone oil, and 5-fluorouracil in the management of experimental PVR. Int Ophthalmol 22: 239-46, 1998-99
24. Herrero-Vanrell R., Ramirez L., Fernandez-Carballido A., et al. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process. Pharm Res 17 (2000) 1323-1328
25. Herrero-Vanrell R., and Refojo M.F. Biodegradable microspheres for vitreoretinal drug delivery. Adv Drug Deliv Rev 52 (2001) 5-16
26. Hiscott P., Magee R.M., Colthurst M., et al. Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade. Br J Ophthalmol 85 (2001) 179-183
27. Hoerauf H., and Laqua H. Severe emulsification after combined use of a partially fluorinated alkane and silicone oil. Graefes Arch Clin Exp Ophthalmol 240 (2002) 131-136
28. Hoerauf H., Roider J., Kobuch K., et al. Perfluorohexylethan (O62) as ocular endotamponade in complex vitreoretinal surgery. Retina 25 (2005) 479-488
29. Hong Y., Chirila T.V., Vijayasekaran S., et al. Crosslinked poly(1-vinyl-2-pyrrolidinone) as a vitreous substitute. J Biomed Mater Res 30 (1996) 441-448
30. Hong Y., Chirila T.V., Fitton J.H., et al. Effect of crosslinked poly(1-vinyl-2-pyrrolidinone) gels on cell growth in static cell cultures. Biomed Mater Eng 7 (1997) 35-47
31. Hong Y., Chirila T.V., Vijayasekaran S., et al. Biodegradation in vitro and retention in the rabbit eye of crosslinked poly(1-vinyl-2-pyrrolidinone) hydrogel as a vitreous substitute. J Biomed Mater Res 39 (1998) 650-659
32. John G.R., Lee S.C., and Brosnan C.F. Cytokines: powerful regulators of glial cell activation. Neuroscientist 9 (2003) 10-22
33. Kimura H., Ogura Y., Hashizoe M., et al. A new vitreal drug delivery system using an implantable biodegradable polymeric device. Invest Ophthalmol Vis Sci 35 (1994) 2815-2819
34. Kirchhof B., Wong D., Van Meurs J., et al. Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 133 (2002) 95-101
35. Kloth S., Kobuch K., Domokos J., et al. Polar application of test substances in an organotypic environment and under continuous medium flow: a new tissue-based test concept for a broad range of applications in pharmacotoxicology. Toxicol In Vitro 14 (2000) 265-274
36. Kobuch K., Menz I.H., Hoerauf H., et al. New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 239 (2001) 635-642
37. Kociok N., Gavranic C., Kirchhof B., et al. Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane. Graefes Arch Clin Exp Ophthalmol 243 (2005) 345-358
38. Limb G.A., Salt T.E., Munro P.M., et al. In vitro characterization of a spontaneously immortalized human Müller cell line (MIO-M1). Invest Ophthalmol Vis Sci 43 (2002) 864-869
39. Liu K.R., Peyman G.A., and Miceli M.V. Experimental evaluation of low-viscosity fluorosilicone oil as a temporary vitreous substitute. Ophthalmic Surg 20 (1989) 720-725
40. Maberley A.L., and Antworth M.V. The use of silicone oil in vitreoretinal surgery. Can J Ophthalmol 24 (1989) 265-268
41. Malchiodi-Albedi F., Feher J., Caiazza S., et al. PEDF (pigment epithelium-derived factor) promotes increase and maturation of pigment granules in pigment epithelial cells in neonatal albino rat retinal cultures. Int J Dev Neurosci 16 (1998) 423-432
42. Malchiodi-Albedi F., Perilli R., Formisano G., et al. Perfluorodecalin modifies the pattern of cell arrangement and induces loss of neurites in rat retinal cultures. J Biomed Mater Res 41 (1998) 608-613
43. Malchiodi-Albedi F., Morgillo A., Formisano G., et al. Biocompatibility assessment of silicone oil and perfluorocarbon liquids used in retinal reattachment surgery in rat retinal cultures. J Biomed Mater Res 60 (2002) 548-555
44. Malchiodi-Albedi F., Matteucci A., Formisano G., et al. Perfluorohexyloctane (F6H8) induces structural modifications and increases apoptosis in rat primary retinal cultures. J Biomed Mater Res B Appl Biomater 65 (2003) 133-136
45. Malchiodi-Albedi F., Matteucci A., Formisano G., et al. Induction of apoptosis in rat retinal cell cultures by partially fluorinated alkanes. Am J Ophthalmol 139 (2005) 737-739
46. Martínez-Sancho C., Herrero-Vanrell R., and Negro S. Poly (D,L-lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: influence of fatty and non-fatty additives. J Microencapsul 20 (2003) 799-810
47. Maruoka S., Matsuura T., Kawasaki K., et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res 31 (2006) 599-606
48. Meinert H., and Roy T. Semifluorinated alkanes-a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol 10 (2000) 189-197
49. Meller D., Augustin A.J., Spitznas M., et al. Effects of different perfluorochemicals on dorsal root ganglion cells in vitro. Graefes Arch Clin Exp Ophthalmol 236 (1998) 182-187
50. Mertens S., Bednarz J., and Engelmann K. Evidence of toxic side effects of perfluorohexyloctane after vitreoretinal surgery as well as in previously established in vitro models with ocular cell types. Graefes Arch Clin Exp Ophthalmol 240 (2002) 989-995
51. Orzalesi N., Migliavacca L., Bottoni F., et al. Experimental short-term tolerance to perfluorodecalin in the rabbit eye: a histopathological study. Curr Eye Res 17 (1998) 828-835
52. Peyman G.A., Schulman J.A., and Sullivan B. Perfluorocarbon liquids in ophthalmology. Surv Ophthalmol 39 (1995) 375-395
53. Ratiglia R., Berti E., Galimberti D., et al. Experimental vitreous replacement with perfluorophenanthrene. Eur J Ophthalmol 7 (1997) 59-63
54. Rizzo S., Genovesi-Ebert F., Belting C., et al. A pilot study on the use of silicone oil-RMN3 as heavier-than-water endotamponade agent. Graefes Arch Clin Exp Ophthalmol 28 (2005) 1-5
55. Rodriguez Boulan E., and Sabatini D.D. Asymmetric budding of viruses in epithelial monolayers: a model system for study of epithelial polarity. Proc Natl Acad Sci USA 75 (1978) 5071-5075
56. Rodriguez M., and Schaper J. Apoptosis: measurement and technical issues. J Mol Cell Cardiol 38 (2005) 15-20
57. Roider J., Hoerauf H., Kobuch K., et al. Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligomers) in complicated retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 240 (2002) 965-971
58. Rosemberg M.D. The culture of cells and tissues at the saline-fluorocarbon interface. In: Ramakrishnan C.V. (Ed). Baroda Tissue Culture Seminar (1965), Junk, The Hague, Netherlands 93-107
59. Saxena S., and Gopal L. Fluid vitreous substitutes in vitreo retinal surgery. Indian J Ophthalmol 44 (1996) 191-206
60. Schatz B., El-Shabrawi Y., Haas A., et al. Adverse side effects with perfluorohexyloctane as a long-term tamponade agent in complicated vitreoretinal surgery. Retina 24 (2004) 567-573
61. Singh J., Ramaesh K., Wharton S.B., et al. Perfluorodecalin-induced intravitreal inflammation. Retina 21 (2001) 247-251
62. Sobel S., and Rosenberg M.D. Characterization of cellular attachment and spreading molecules at liquid-liquid interfaces. Anal Biochem 140 (1984) 486-489
63. Soman N., and Banerjee R. Artificial vitreous replacements. Biomed Mater Eng 13 (2003) 59-74
64. Sparrow J.R., Jayakumar A., Berrocal M., et al. Experimental studies of the combined use of vitreous substitutes of high and low specific gravity. Retina 12 (1992) 134-140
65. Sparrow J.R., Ortiz R., MacLeish P.R., et al. Fibroblast behavior at aqueous interfaces with perfluorocarbon, silicone, and fluorosilicone liquids. Invest Ophthalmol Vis Sci 31 (1990) 638-646
66. Stolba U., Krepler K., Pflug R., et al. Experimental vitreous and aqueous replacement with perfluorophenanthrene. Clinical, histologic, and electrophysiologic results. Retina 17 (1997) 146-153
67. Stolba U., Krepler K., Velikay-Parel M., et al. The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution. Graefes Arch Clin Exp Ophthalmol 242 (2004) 931-936
68. Suri S., and Banerjee R. In vitro evaluation of in situ gels as short term vitreous substitutes. J Biomed Mater Res 79A (2006) 650-664
69. Theelen T., Tilanus M.A., and Klevering B.J. Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch Clin Exp Ophthalmol 242 (2004) 617-620
70. Triviño A., Ramírez J.M., Ramírez A.I., et al. Comparative study of astrocytes in human and rabbit retinae. Vision Res 37 (1997) 1707-1711
71. Velikay M., Stolba U., Wedrich A., et al. The effect of chemical stability and purification of perfluorocarbon liquids in experimental extended-term vitreous substitution. Graefes Arch Clin Exp Ophthalmol 233 (1995) 26-30
72. Versura P., Cellini M., Torreggiani A., et al. The biocompatibility of silicone, fluorosilicone and perfluorocarbon liquids as vitreous tamponades. an ultrastructural and immunohistochemical study. Ophthalmologica 215 (2001) 276-283
73. Vote B., Wheen L., Cluroe A., et al. Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Experiment Ophthalmol 31 (2003) 408-414
74. Winter M., Eberhardt W., Scholz C., and Reichenbach A. Failure of potassium siphoning by Muller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci 41 (2000) 256-261
75. Wolf S., Schön V., Meier P., and Wiedemann P. Silicone oil RMN3 mixture (heavy silicone oil) as internal tamponade for complicated retinal detachment. Retina 23 (2003) 335-342
76. Wong D., and Lois N. Perfluorocarbons and semifluorinated alkanes. Semin Ophthalmol 15 (2000) 25-35
77. Zeana D., Becker J., Kuckelkorn R., and Kirchhof B. Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol 23 (1999) 17-24